Every material Form 8-K Brunswick filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Brunswick reported third-quarter 2025 net sales of $1.36 billion, up 6.8% from a year earlier, but a GAAP diluted loss of $3.57 per share, driven by $333.8 million of restructuring, exit and impairment charges. As adjusted diluted EPS fell 17.1% to $0.97, and the company confirmed full-year adjusted EPS guidance of approximately $3.25 while raising its free cash flow guidance to more than $425 million.
Net sales of $1,360.2 million, up from $1,273.3 million in the third quarter of 2024.
GAAP diluted EPS of $(3.57), including $333.8 million of restructuring, exit and impairment charges; as adjusted diluted EPS of $0.97 versus $1.17 a year earlier.
Full-year 2025 as adjusted diluted EPS guidance of approximately $3.25 confirmed; free cash flow guidance raised to greater than $425 million.
Third-quarter free cash flow of $111 million and $355 million year to date.
Brunswick reported second quarter 2025 net sales of $1,447.0 million, roughly flat year over year, while GAAP diluted EPS fell to $0.90 from $1.55 and as adjusted diluted EPS fell to $1.16 from $1.80. The company kept its full-year as adjusted diluted EPS guidance midpoint at approximately $3.25 and raised its free cash flow expectation to more than $400 million, but provided Q3 adjusted EPS of $0.75 to $0.90 on revenue of $1.1 to $1.3 billion, which is below the prior-year level.
Q2 2025 net sales $1,447.0 million, up 0.2% from $1,443.9 million; GAAP operating earnings $103.3 million, down 34.7%
Full-year 2025 guidance: net sales of approximately $5.2 billion, as adjusted diluted EPS of approximately $3.25, free cash flow above $400 million
Q3 2025 guidance: revenue of $1.1 to $1.3 billion and as adjusted diluted EPS of $0.75 to $0.90
Free cash flow of $288 million in Q2 2025, a second-quarter record; $43 million of share repurchases through the second quarter
Brunswick reported first quarter 2025 net sales of $1,221.8 million, down 10.5% from a year earlier, with GAAP diluted EPS of $0.30 and adjusted diluted EPS of $0.56, both sharply lower than the prior year. The company also issued updated full-year 2025 guidance of $5.0 billion to $5.4 billion in net sales and adjusted diluted EPS of $2.50 to $4.00, and second-quarter guidance of $1.1 billion to $1.3 billion in revenue. The filing does not state the prior guidance, so the direction of the update cannot be determined from this document.
Q1 2025 net sales of $1,221.8 million, down from $1,365.0 million in Q1 2024
GAAP diluted EPS of $0.30 vs. $1.00 a year earlier; adjusted diluted EPS of $0.56 vs. $1.35
Updated 2025 guidance: net sales $5.0 billion to $5.4 billion; adjusted diluted EPS $2.50 to $4.00; free cash flow above $350 million
Q2 2025 guidance: revenue of $1.1 billion to $1.3 billion and adjusted diluted EPS of $0.80 to $1.10
Brunswick reported fourth-quarter 2024 net sales of $1,154.9 million, down from $1,361.9 million a year earlier, and a GAAP diluted loss of $(1.07) per share compared with earnings of $1.03 per share in the prior-year quarter. For full-year 2024, GAAP diluted EPS fell 63.9% to $2.21, and adjusted diluted EPS fell 48.1% to $4.57, while the company guided to 2025 net sales of $5.2 billion to $5.6 billion and adjusted diluted EPS of $3.50 to $5.00.
Q4 2024 net sales were $1,154.9 million, down 15.2% from $1,361.9 million in Q4 2023.
Q4 2024 GAAP diluted EPS was $(1.07), versus $1.03 a year earlier; as adjusted EPS was $0.24, down 83.4%.
Full-year 2024 GAAP diluted EPS was $2.21, down 63.9%; as adjusted diluted EPS was $4.57, down 48.1%.
2025 guidance calls for net sales of $5.2 billion to $5.6 billion and adjusted diluted EPS of $3.50 to $5.00; first-quarter 2025 adjusted EPS is guided to $0.15 to $0.25.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Brunswick filing is on SEC EDGAR ↗. 8-K briefs of other companies →